Plasma pharmacokinetics of adriamycin after intrapleural administration
Medical Oncology and Tumor Pharmacotherapy · 1984
DOI: 10.1007/bf02934140 ↗At a glance
Journal article in Medical Oncology and Tumor Pharmacotherapy, 1984. Written by S Eksborg and 2 co-authors. Cited 4 times so far (Crossref); 16 references.
Abstract (original language)
The plasma pharmacokinetics of adriamycin after intrapleural administration have been studied. The maximum plasma concentration found after intrapleural instillation of 50 mg was 100 ng ml-1, the adriamycin half-life being about 2.5 h. Large amounts of the drug are adsorbed from the pleura. Hence risks for cardiomyopathy, previously associated with the repeated intravenous administration of adriamycin, must also be considered after intrapleural administration.
Subjects
MeSH terms (MEDLINE)
Substances
Cite
APA
Eksborg, S., Lindfors, A., & Cedermark, B. J. (1984). Plasma pharmacokinetics of adriamycin after intrapleural administration. Medical Oncology and Tumor Pharmacotherapy. https://doi.org/10.1007/bf02934140
Vancouver
Eksborg S, Lindfors A, Cedermark BJ. Plasma pharmacokinetics of adriamycin after intrapleural administration. Medical Oncology and Tumor Pharmacotherapy. 1984. doi:10.1007/bf02934140
BibTeX
@article{Eksborg1984,
author = {Eksborg, S and Lindfors, A and Cedermark, B J},
title = {Plasma pharmacokinetics of adriamycin after intrapleural administration},
journal = {Medical Oncology and Tumor Pharmacotherapy},
year = {1984},
doi = {10.1007/bf02934140}
}
EUVIMED